Clinical Trial: The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980922) titled 'The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension' on May 19.

Brief Summary: The goal of this clinical trial is to learn if Guilu Erxian Jiao, a traditional Chinese herbal medicine, can help manage intradialytic hypotension (IDH), a drop in blood pressure that occurs during hemodialysis in adults. The main questions it aims to answer are:

1. Does Guilu Erxian Jiao reduce the frequency and severity of low blood pressure during dialysis?

2. Is Guilu Erxian Jiao safe to use in patients receiving hemodialysis?

Researchers will compare standard care plus Guilu ErXian Jiao to standard care alone ...